Medical Advices

If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!

HARBIN, China, May 29 /Xinhua-PRNewswire-FirstCall/ — China Sky One Medical, Inc. (”China Sky One Medical”, “CSY”), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that it is donating external-use medicine worth a total of RMB 1,115,300 to Heilongjiang Foundation and Red Cross China for earthquake disaster relief efforts.
The management of China Sky One Medical has been very concerned with the disaster relief efforts ever since the earthquake struck Sichuan province on May 12, 2008. The earthquake led to significant loss of life and property. “As an entrepreneurial company, we have received a lot of support from the people and the surrounding communities over the years. It is our duty to do whatever we can to give back to the communities, especially during this difficult time,” said Mr. Yanqing Liu, Chairman and CEO of China Sky One Medical.
Since May 17th, all the medicine donated by the Company has been delivered to regions struck by the disaster by Heilongjiang Foundation and Red Cross China. The donations consisted primarily of medicine for the treatment of injuries due to contusion, sprains and fractures, the most common problems observed among the earthquake victims.
Since its inception, the Company has operated under the principal of “serving the people, managing with integrity.” Over the years, the Company, together with the surrounding communities, have faced and overcome numerous challenges. The total value that China Sky One Medical has donated to the communities since its founding is in excess of RMB 5 million, for causes ranging from disaster relief for the flood in 1998 to donations for the construction of schools, to donations to alleviate poverty and care for the elderly.
“We feel a strong sense of responsibility and believe all Chinese people should form a united front to combat the pain and suffering following this natural disaster. Going forward, we will not only donate medicine to help the victims in the regions affected by the earthquake, but we will also send healthcare professionals to the regions that were hit the hardest by earthquake and leverage our new biotechnology test kits to perform early diagnosis on victims,” concluded Mr. Liu.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned PRC based subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company Harbin First Bio- Engineering Company Limited and Heilongjiang Tianlong Pharmaceutical, Inc., the Company manufactures and distributes over-the-counter pharmaceutical products as its primary revenue source. For more information, visit .
Safe Harbor Statement
Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as “believe,”"expect,”"may,”"will,”"should,”"project,”"plan,”"seek,”"intend,” or “anticipate” or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the inability of the company to meet the listing standards, risks associated with the effect of changing economic conditions in The People’s Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange.
For more information, please contact:

Company Contact:
China Sky One Medical, Inc.
Mr. Liao Xiaoqing, CFO
Phone: 86-1591-067-2198
Email:

Investor Relations Contact:
CCG Elite Investor Relations Inc.
Mr. Crocker Coulson, President
Phone: 1-646-213-1915 (New York)
Email:
Web:
China Sky One Medical, Inc.

GUANGZHOU, China, May 29 /Xinhua-PRNewswire/ — China medicine Corporation (BULLETIN BOARD: CHME) (”China Medicine” or “the Company”), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (”TCM”), nutritional and dietary-supplements, medical devices, and medical formulations in the People’s Republic of China (”PRC”), announced that it held its 2008 Annual General Meeting of Shareholders (the “AGM”) on May 16th, 2008, in New York City.
At the meeting, the proposal for the election of five directors to serve until the AGM in 2009, as set out in the Company’s definitive Proxy Statement, was approved. Specifically, the shareholders elected Mr. Senshan Yang, Ms. Minhua Liu, Mr. Robert Alder, Ms. Rachel Gong and Mr. Yanfang Chen as members of the Board of Directors of the Company.
About China medicine Corporation
China medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces and to more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company’s website at .
Cautionary Statement
This press release contains forward-looking statements concerning the Company’s business and products. The Company’s actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company’s reports filed with the Securities and Exchange Commission. China medicine Corporation undertakes no duty to revise or update any forward- looking statement to reflect events or circumstances after the date of this release.
For more information, please contact:

Company Contact:
Ms. Huizhen Yu
Chief Financial Officer
China medicine Corp
Tel: 86-20-8739-1718
Email:
Website:

Investor Relations Contact:
Mr. Crocker Coulson
President
CCG Elite Investor Relations
Tel: 1-646-213-1915 (NY Office)
Email:
Website:
China medicine Corporation

WASHINGTON, May 29 /PRNewswire-USNewswire/ — Personalized medicine, which uses genetic information to tailor treatments to specific individuals, is a revolutionary healthcare option, filled with potential but also containing serious challenges for average patients, writes Beryl Lieff Benderly, in an Insighter piece posted on , the website of the Food and Drug Law Institute (FDLI).
In the Insighter piece, Personalized Medicine: A Challenging Revolution in Healthcare, Nina Scribanu, MD, associate professor of pediatrics and director of the division of genetics at the Georgetown University Medical Center, tells FDLI that much work remains in the development of personalized medicine before patients can receive the full benefits of its potential.
However, the article asserts, genomic medicine is clearly rocketing forward. “This is our chance to transform medicine from ‘one-size- fits-all’ to a potentially personalized approach,” said Francis Collins, MD, PhD, director of the National Human Genome Research Institute, in testimony before Congress. “Already, healthcare providers can test whether some of us carry DNA variants that predispose us to certain diseases, and new research efforts could help to expand this capability and possibly offer better opportunities for preventive measures. If illness does occur, doctors will have more powerful tools to identify the molecular causes, and to prescribe medicines based on individualized genetic information.”
Genetic information already is helping doctors to individualize some treatments. One genetic test, for example, can determine which patients with hepatitis C need drug therapy for 48 weeks as opposed to the conventional 24 weeks. Another can distinguish women with breast cancer who are likely to relapse and therefore would benefit from chemotherapy from those unlikely to relapse, who do not need these expensive and toxic drugs. Other tests differentiate breast cancer patients likely to benefit from the drug herceptin from those likely to suffer adverse side effects. Yet other tests can help doctors prescribe appropriate dosages of powerful drugs by identifying individuals who metabolize them quickly, at an average rate, or not at all.
But Scribanu maintains that “there is insufficient support for young people to go into clinical practice” of genetic medicine. “Much of the talent is going to private companies” that develop and market tests rather than into clinical care that uses this knowledge with individual patients, she explains. “This is a field that needs support,” Scribanu concludes.
FDLI and the American Association for the Advancement of Science (AAAS) are sponsoring a national conference, Personalized Medicine: Promises and Challenges, June 20, 2008, at AAAS Headquarters in Washington, D.C. The meeting will include a high-level roundtable discussion in the morning and a seminar on legal, regulatory and policy issues on personalized medicine in the afternoon.
For more information on the personalized medicine conference, visit or contact Michael Levin-Epstein, Editor-in-Chief, (202) 222-0897 or .
The full text of the Insighter piece is posted at
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.
Food and Drug Law Institute

VANCOUVER, British Columbia, May 30 /PRNewswire-FirstCall/ — Current technology Corporation (OTCBB: CRTCF) today announced its 51% owned Texas-based subsidiary Celevoke, Inc. (”Celevoke”) has completed a definitive distribution agreement with The Real Security Company Ltd. (”TRSC”) of Kelowna, British Columbia. “We are shipping 700 GPS Tracking units today,” stated Celevoke Vice-president Brian Allen, “and plan to ship a further 1000 units next week.”
“The first 700 units are already placed,” said TRSC CEO Eldon Heppner. “Five hundred will be delivered to automobile and power sports equipment dealers in British Columbia and Alberta, Canada. The remaining two hundred are for dealers in Florida and Texas. This is just the beginning. These units prime the pump in very limited geographic areas. We plan to blanket North America with Celevoke units marketed under our EYE-ON brand. We believe we will soon be purchasing thousands of units per month on a regular basis.”
“We are very excited about TRSC’s plans,” stated Current technology CEO Robert Kramer. “We believe these first two shipments totaling 1700 units represent the leading edge of a sophisticated marketing strategy which should see tens of thousands of units sold into many markets from automotive and power sports equipment to pupil transportation to name just a few.”
About Celevoke
Celevoke is poised to become a market leader in the projected $38.3 billion (by 2011) global market for Telematics (according to ABI Research), which is the integrated use of telecommunications and informatics. More specifically, it is the science of sending, receiving and storing information wirelessly via telecommunication devices. Celevoke has integrated Telematics and Global Positioning Systems (GPS) with sensing technology. This proprietary suite of hardware and software products enables users to remotely monitor, track, control and protect a wide variety of asset classes. Examples include people, automobiles and trucks, shipping containers and covert vehicles used for law enforcement and intelligence gathering in a global marketplace. In 2005, Celevoke acquired the assets of San Francisco based Televoke, Inc.; a telematics pioneer backed by Softbank Venture Capital, Cardinal Venture Capital, W.I. Harper Group and others, representing more than $15 million in funding. These assets provided the foundation for Celevoke’s development of patented technology utilized today by Celevoke’s many clients.
Forward Looking Statement
The news release contains forward-looking statements concerning the Company’s business operations, and financial performance and condition. When used in the news release the words “believe,”"anticipate,”"intend,”"estimate,”"expect,”"project,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such words. These forward-looking statements are based on current expectations and are naturally subject to uncertainty and changes in circumstances that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause such differences include but are not limited to technological change, regulatory change, the general health of the economy and competitive factors. Many of these factors are beyond the Company’s control; therefore, future events may vary substantially from what the Company currently foresees. You should not place undue reliance on such forward-looking statements.
Current technology Corporation

NEW YORK, April 29 /PRNewswire-USNewswire/ — mtvU, MTV’s Peabody and Emmy Award-winning college network, and the Kaiser Family Foundation, in partnership with POZ Magazine, today unveiled “Pos or Not” ( an online game that challenges stereotypes and breaks down the barriers that may prevent people from talking openly about HIV/AIDS, getting tested, and using protection.
People from across the U.S. - half of whom are living with HIV and half who are not - share parts of their lives for “Pos or Not” by divulging their HIV status to help dispel myths and misconceptions about HIV and AIDS. Players confront their own HIV stereotypes as they guess whether a profiled participant is positive or negative based only on a photo and a few personal details, such as what they do on the weekends or their favorite kind of music.
Among the participants who are positive, we’re provided a window on the circumstances in which they learn their HIV status - including after the birth of a child, calls from ex-lovers, and long-postponed HIV tests. HIV negative participants share how the disease has touched their lives, claiming boyfriends, girlfriends, mothers and best friends. Every individual stresses that HIV affects everyone and that the only way to truly know your own or some else’s HIV status is by getting tested.
While “Pos or Not” confronts stereotypes and popular misconceptions about HIV/AIDS, it also provides users with information about HIV prevention, as well as local HIV and STD testing resources from the U.S. Centers for Disease Control & Prevention (CDC). In addition, players are invited to join the game to help underscore that there’s no way to tell a person’s HIV status from how they look or what they do.
Several of the most requested acts on college campuses and major pop culture figures are also lending their efforts to help stoke the online viral spread of “Pos or Not,” including Wyclef Jean, Fall Out Boy, Will.i.am, Alyssa Milano, Say Anything, Perez Hilton, Angels & Airwaves, Atmosphere, The Spill Canvas, 30 Seconds to Mars, Aesop Rock, Motion City Soundtrack, All Time Low and Rise Against. Beginning today, these and many others are sending the game to their fans, families and friends, via a feature that allows users to share “Pos or Not” with everybody in their e-mail address books with only a couple clicks.
“‘Pos or Not’ is an urgent analogue to HotorNot.com, designed to capture college students’ attention and harness the viral nature of the Web in the ongoing fight against the spread of HIV/AIDS,’” said Stephen Friedman, GM, mtvU. “‘Pos or Not’ was created to shatter myths, challenge assumptions and promote responsible sexual behavior - and we salute every participant, as well as the team of college students who conceived the game, for breathing life into it.”
“‘Pos or Not’ confronts the stigma and stereotypes that fuel the continued spread of this disease some 25 years since the first diagnosis,” said Tina Hoff, vice president and director of Entertainment Media Partnerships at the Kaiser Family Foundation. “‘Pos or Not’ has the powerful effect of allowing young people across the country to learn more about those infected and affected by HIV/AIDS and in doing so hopefully form a more personal understanding of the disease.”
“The HIV-positive community has the unique ability to debunk myths and dissolve dangerous stereotypes around HIV/AIDS,” said Regan Hofmann, editor-in-chief of POZ magazine. “Having a face-to-face encounter with a person living with the virus can also positively affect the choices people make regarding behaviors that can lead to their contracting HIV. I think that ‘Pos or Not’ is a wonderful way to allow the HIV community to serve as an awareness and prevention tool for those who are - but who do not believe themselves to be - at risk.”
“Pos or Not” was inspired by the winners of the “Change the Course of HIV Challenge,” a nationwide competition that asked college students to propose a viral, Web-based game that would creatively engage people to help combat the spread of HIV/AIDS. The winning concept was submitted by a team from the Florida Interactive Entertainment Academy and included designers Brendan McLeod and Matthew Laurence, programmers Chris Camilleri and Gabriel Montagne, and artist Chip Lundell.
College students helped conceive “Pos or Not” and are pioneering the future of digital activism every day, so mtvU, the Kaiser Family Foundation and POZ Magazine are calling on users to imagine ways the game can be even more viral and impactful. Anyone with a vision for how “Pos or Not” can be effectively executed on other platforms (mobile, social networks, etc.), remixed, or in any way serve as an even more powerful call to action on the HIV/AIDS epidemic are encouraged to send ideas to . mtvU and the Kaiser Family Foundation are committing to incorporate the best concepts into future versions of the game - or a completely re-imagined iteration - so it continues to evolve and reach more people.
“Pos or Not” follows on the success of “Darfur is Dying” (), mtvU’s student-developed videogame - now played more than 3 million times by over 1.5 million people - designed to spread awareness of and spur action to end the genocide in Darfur. “Darfur is Dying” is a narrative-based simulation where the user, from the perspective of a displaced Darfurian, negotiates forces that threaten the survival of his or her refugee camp. The game is a key element of mtvU’s nearly four-year, student-led, Emmy Award-winning Sudan campaign.
Representatives from mtvU and the Kaiser Family Foundation will be presenting “Pos or Not” at the fourth annual Games for health Conference, taking place May 8 - 9 in Baltimore, Maryland. To learn more about the conference, please visit .
About The Kaiser Family Foundation
The Kaiser Family Foundation is a non-profit, private operating foundation dedicated to providing information and analysis on health care issues to policymakers, the media, the health care community, and the general public. The foundation is not associated with Kaiser Permanente or Kaiser Industries. Information on HIV/AIDS is available at , and a daily news summary report on developments in HIV/AIDS is available on , the Foundation’s free health information service.
About mtvU
Broadcast to more than 750 college campuses and via top cable distributors in 700 college communities nationwide, mtvU reaches upwards of 9 million U.S. college students - making it the largest, most comprehensive television network just for college students. Twenty-four hours a day, seven days a week, mtvU can be seen in the dining areas, fitness centers, student lounges and dorm rooms of campuses throughout the U.S, as well as on cable systems from Charter Communications, Verizon FiOS TV, Suddenlink Communications, AT&T u-Verse and nearly 70 others. mtvU is dedicated to every aspect of college life, reaching students everywhere they are: on-air, online and on campus. mtvU programs music videos from emerging artists that can’t be seen anywhere else, news, student life features and initiatives that give college students the tools to advance positive social change. mtvU is always on campus, with more than 500 events per year, including exclusive concerts, giveaways, shooting mtvU series and more. For more information about mtvU, and a complete programming schedule, visit .
mtvU also owns and operates the College Media Network, the largest interactive network of online college newspapers in the US, and RateMyProfessors.com, the Internet’s largest listing of collegiate professor ratings. The College Media Network comprises nearly 600 campus publications that serve institutions including Brown University, the University of Illinois, the University of Southern California, the University of Texas at Austin and Duke University, with a combined enrollment of over 5.5 million students, reaching an average of 5 million unique users each month. RateMyProfessors.com reaches approximately 2.9 million college students each month, via the site’s more than 6.6 million student-generated ratings of over 1,000,000 college professors.
MTV Networks, a unit of Viacom , is one of the world’s leading creators of programming and content across all media platforms. MTV Networks, with more than 150 channels worldwide, owns and operates the following television programming services - MTV: MUSIC TELEVISION, MTV2, VH1, mtvU, NICKELODEON, NICK at NITE, COMEDY CENTRAL, TV LAND, SPIKE TV, CMT, NOGGIN/THE N, VH1 CLASSIC, MTVN INTERNATIONAL and THE DIGITAL SUITE FROM MTV NETWORKS, a package of 13 digital services, all of these networks trademarks of MTV Networks. MTV Networks connects with its audiences through its robust consumer products businesses and its more than 300 interactive properties worldwide, including online, broadband, wireless and interactive television services and also has licensing agreements, joint ventures, and syndication deals whereby all of its programming services can be seen worldwide.
About POZ
POZ is the premier lifestyle, treatment and advocacy magazine for people living with — and those affected by — HIV and AIDS. The award-winning magazine and website () provide the most complete and expert HIV/AIDS information available in the United States. Together, the magazine and website reach more than 70 percent of all of those living with HIV/AIDS who are aware of their status. The website provides extensive opportunity for both public and private social networking and represents one of the largest communities of openly HIV-positive people in the world. For more information, please visit .
###
Henry J. Kaiser Foundation

NEW YORK, May 21 /PRNewswire/ — This May 23-25, the Chopra Center for Wellbeing is coming to New York City with Renewal Weekend, where renowned authors, physicians, and Chopra Center co-founders, Deepak Chopra & David Simon, will help guests discover their personal path to true health and well-being.
Renewal Weekend is the ideal starting point for individuals who want to explore holistic healing but have been too busy or harried to figure out where to begin. Drs. Deepak Chopra and David Simon designed Renewal Weekend as a practical introduction to mind-body medicine and Ayurveda — the holistic system of medicine that developed in India thousands of years ago.
“The Chopra Center has developed a healing approach that combines the healing arts of the East with the best in modern Western medicine,” said Dr. Chopra. “Renewal Weekend is about helping participants benefit from this approach in their own lives. Those who join us in New York will learn daily practices for releasing stress, emotional turmoil, and physical pain.”
Renewal Weekend is a rare opportunity to personally experience Deepak Chopra, M.D. and David Simon, M.D. as they teach you essential tools and techniques to revitalize your body and mind, including:
— Primordial Sound Meditation
— Mind-body integration and Ayurveda
— The wisdom of natural herbs and your inner pharmacy
— Revitalizing yoga classes (all levels)
— Holistic techniques for releasing stress and anxiety
— A personal daily routine for calm, renewal, and balance

Renewal Weekend takes place at the Park Central Hotel — just blocks away from Central Park, and only minutes from the Chopra Center & Spa at Dream, one of the only places in the U.S. that offers authentic Ayurvedic massage treatments.
For more information, please call 888.736.6895 or visit .
About the Chopra Center
The Chopra Center for Wellbeing was founded by Deepak Chopra, M.D. and David Simon, M.D. in 1996. Located in Carlsbad, California, the Center offers a wide variety of programs, retreats, and teacher training programs that integrate the healing arts of the East with the best in modern Western medicine. The Chopra Center has helped millions of people around the world find peace of mind, physical balance, and emotional healing. The website is your starting point on the path to wellness.
Dr. Deepak Chopra is co-founder of The Chopra Center for Wellbeing and a best-selling author who has written more than 50 books in 25 languages. He is acknowledged as one of the world’s greatest leaders in the field of mind-body medicine. Through The Chopra Center, Dr. Chopra is revolutionizing common wisdom about the crucial connection between body, mind, spirit, and healing.
Dr. David Simon is the co-founder, medical director, and CEO of The Chopra Center for Wellbeing — as well as a board certified neurologist and a pioneer in the integration of Western medicine and the healing arts of the East. Dr. Simon is the recipient of a National Institutes of Health grant to study mind-body approaches to health, and has created initiatives to bring holistic health-care programs to medical institutions, community health centers, and health resorts. In addition, he is a best-selling author whose recent books include The Ten Commitments: Translating Good Intentions into Good Choices and Vital Energy: The 7 Keys to Invigorate Body, Mind, and Soul. His latest book is Freedom from Addiction, co-authored with Dr. Deepak Chopra.
Chopra Center for Wellbeing

CARLSBAD, Calif., May 28 /PRNewswire/ — Valencia Porter, M.D., M.P.H. has joined the medical staff of the Chopra Center for Wellbeing — the integrative wellness center founded by world-renowned mind-body physicians Deepak Chopra and David Simon.
Board-certified in both General Preventive medicine and Integrative Holistic Medicine, Dr. Porter has an approach that incorporates many systems of health and complementary healing. A graduate of Keck School of medicine at the University of Southern California, she completed a residency in Preventive medicine at U.C. San Diego in addition to her training in Pediatrics and Child Neurology at UCLA and UCSD. She has also received further education in medical acupuncture, Ayurveda, and Healing Touch — as well as earning a master’s degree in public health.
“Dr. Porter has a unique expertise that bridges the wisdom of the Eastern healing traditions with modern Western medicine,” said Dr. Chopra. “Her integrative approach fits perfectly with the philosophy and practices of the Chopra Center.”
Before coming to the Chopra Center, Dr. Porter served as a physician and researcher at the Scripps Center for Integrative medicine in La Jolla, where she provided integrative care to children and adults coping with ADD/ADHD, stress and anxiety, depression, chronic pain, and weight management. Dr. Porter is currently completing a fellowship at the Program for Integrative medicine at the University of Arizona, where she is a Bravewell Collaborative scholar.
Dr. Porter’s mind-body medical consultations are available for weekly guests of Perfect Health, daily out-patients, and visitors to the Chopra Center in Carlsbad, California.
To learn more, please call 888.736.6895 or visit .
About the Chopra Center
The Chopra Center for Wellbeing was founded by Deepak Chopra, M.D. and David Simon, M.D. in 1996. Located in Carlsbad, California, the Center offers a wide variety of programs, retreats, and teacher training programs that integrate the healing arts of the East with the best in modern Western medicine. The Chopra Center has helped millions of people around the world find peace of mind, physical balance, and emotional healing. The website is your starting point on the path to wellness.
Dr. Deepak Chopra is co-founder of The Chopra Center for Wellbeing and a best-selling author who has written more than 50 books in 25 languages. He is acknowledged as one of the world’s greatest leaders in the field of mind-body medicine. Through The Chopra Center, Dr. Chopra is revolutionizing common wisdom about the crucial connection between body, mind, spirit, and healing.
Dr. David Simon is the co-founder, medical director, and CEO of The Chopra Center for Wellbeing — as well as a board-certified neurologist and a pioneer in the integration of Western medicine and the healing arts of the East. Dr. Simon is the recipient of a National Institutes of Health grant to study mind-body approaches to health, and has created initiatives to bring holistic health-care programs to medical institutions, community health centers, and health resorts. In addition, he is a best-selling author whose recent books include The Ten Commitments: Translating Good Intentions into Good Choices and Vital Energy: The 7 Keys to Invigorate Body, Mind, and Soul. His latest book is Freedom from Addiction, co-authored with Dr. Deepak Chopra.
The Chopra Center for Wellbeing

CAMBRIDGE, England and SAN FRANCISCO, May 29 /PRNewswire-FirstCall/ — Autonomy Corporation plc , a global leader in infrastructure software for the enterprise, today announced that it was named a leader in the May 2008 Forrester Wave(TM): Enterprise Search, Q2 2008 report. In this extensive Forrester’s 147-criteria evaluation of the enterprise search vendors, Autonomy received the highest score in all three categories, which include current offering, strategy and market presence. It also received the highest scores for its administration and security capabilities, product strategy and financial resources to support strategy.
The Autonomy FRCP-compliant pan-enterprise search platform, IDOL, automates the retrieval, processing, and management of all information throughout a global organization irrespective of languages, operating systems, and file types, and with high performance, scalability and fault-tolerance.
The report states, “Autonomy’s IDOL solution is the most complete product evaluated with the best core technology architecture and security capabilities…IDOL’s best fit is global, complex, information-intensive enterprises in markets such as finance, pharmaceuticals , and energy, that have the resources and readiness to invest in a single platform for all of their information processing needs.”1
“With more than 17,000 customers worldwide, 350 OEM partners and a market cap of $4 billion, Autonomy’s position as an industry leader has been widely recognized by industry analysts, such as Forrester Research,” said Dr Mike Lynch, CEO of Autonomy. “Autonomy is proud to bring a compelling value proposition to our customers in private and public sectors from all different industries - the ability to automatically analyze and organize all of their enterprise content in real-time, including text, voice and video, bringing a new level of understanding and intelligence to that information.”
Autonomy’s pan-enterprise search platform performs conceptual and contextual analysis and probability matching on information to find the meaning within and the inter-relationships between and among disparate pieces of content. By supporting more than 1,000 different data formats, including structured, semi-structured, and unstructured data, located across 400 different content repositories, Autonomy can search all categories of information repositories in an organization. It is fault-tolerant using load balancing and mirroring, highly scalable, secure, and has sub-second performance on billions of files.
To find out more about Autonomy’s FRCP-compliant pan enterprise search platform, please visit .
1. Forrester Wave(TM): Enterprise Search, Q2 2008
About Autonomy

Autonomy Corporation plc is a global leader in infrastructure software for the enterprise and is spearheading the meaning-based computing movement. Autonomy’s technology forms a conceptual and contextual understanding of any piece of electronic data including unstructured information, be it text, email, voice or video. Autonomy’s software powers the full spectrum of mission-critical enterprise applications including information access technology, BI, CRM, KM, call center solutions, rich media management, information risk management solutions and security applications, and is recognized by industry analysts as the clear leader in enterprise search.
Autonomy’s customer base comprises of more than 17,000 global companies and organizations including: 3, ABN AMRO, AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler Chrysler, Deutsche Bank, Ericsson, Ford, GlaxoSmithKline, Lloyd TSB, NASA, Nestle, the New York Stock Exchange, Reuters, Shell, T-Mobile, the U.S. Department of Energy, the U.S. Department of Homeland Security and the U.S. Securities and Exchange Commission. Autonomy also has over 300 OEM partners and more than 400 VARs and Integrators, numbering among them leading companies such as BEA, Business Objects, Citrix, EDS, IBM Global Services, Novell, Satyam, Sybase, Symantec, TIBCO, Vignette and Wipro. The company has offices worldwide.
The Autonomy Group includes: Autonomy ZANTAZ, the leader in the archiving, e-Discovery and Proactive Information Risk Management (IRM) markets; Autonomy Cardiff, a leading provider of Intelligent Document solutions; Autonomy etalk, award-winning provider of enterprise-class contact center products, Autonomy Virage, a visionary in rich media management and security and surveillance technology and Autonomy Meridio, a leader in records management software.
Autonomy and the Autonomy logo are registered trademarks or trademarks of Autonomy Corporation plc. All other trademarks are the property of their respective owners.
Autonomy Editorial Contacts:

Winifred Shum
Autonomy (US)
1-408-771-6668

Edward Bridges
Financial Dynamics (UK)
44-207-831-3113

Tania Kempf
Cohn & Wolfe (US)
1-650-281-7556

Clare Gayner
Bite Communications (UK)
44(0)20-8834-3454

Autonomy Corporation plc

CHENGDU, China, May 12 /Xinhua-PRNewswire-FirstCall/ — Tianyin Pharmaceutical, Co., Inc., (BULLETIN BOARD: TYNP) , a manufacturer and supplier of modernized traditional Chinese medicine (”TCM”) based in Chengdu, China, today announced that the Company will present at Roth Third Annual China Discovery Tour on Tuesday, May 20, 2008 at 12:40 p.m. Beijing time. The Conference will be held at the Regent Hotel in Beijing, China.
Dr. Guoqing, Jiang, Tianyin’s Chairman and CEO, Mr. Allen Tang, assistant to the CEO, will be representing Tianyin Pharmaceutical at the conference and will be available for one-on-one meetings with analysts and investors throughout the day.
Management will discuss the Company’s current product portfolio, development pipeline, research and development platform, recent financial highlights and its long-term growth strategy.
Participation is by invitation and registration is mandatory. For more information on the conference contact your Roth representative or visit .
About Roth China Discovery Tour
The 3rd Annual China Discovery Tour will feature more than 70 companies in 7 cities throughout China, combining factory visits with management presentations in a mini conference format. This event is another chapter in Roth’s growing commitment to China. Over the past two years Roth has taken investors on more than 60 company visits in mainland China and hosted close to 200 China company presentations at its conferences. For more information about this invite only event, please contact .
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and supplier of modernized Traditional Chinese medicine (”TCM”) in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 523 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 869 employees. Tianyin achieved revenue of $20.4 million and net income of $3.95 million in FY2007 ending June 30, 2007.
Safe Harbor Statement
The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company’s filings with the Securities and Exchange Commission.
For more information, please contact:

For the Company:
Allen Tang, Ph.D., MBA, Assistant to the CEO
Tel: 86-158-2122-5642 (China)
Email:

Investors:
HC International, Inc.
Alan Sheinwald
Tel: 1-914-669-0222 (US)
Email:
Tianyin Pharmaceutical, Co., Inc.

HOUSTON, May 8 /PRNewswire-FirstCall/ — Go Healthy (Pink Sheets: GOHE) announces the initiation of further clinical trials with Cholesterade (R) in three medical settings with an expected patient clinical group of 200 patients in 6 centers around the country. Dr. William Bryan of the Sports medicine Institute at The Methodist Hospital in the Texas Medical Center will coordinate one clinical trial. Dr. Bryan was formerly the Team Physician for the Houston Astros and the former Medical Director of Major League Baseball.
Dr. David Braunreiter of Memorial Hermann Hospital, the Team Physician for the Houston Dynamo and the NFL’s Houston Texans will coordinate a center in Southwest Houston. Dr. Jason Pirozzolo of the Sports medicine Institute at the Florida Hospital in Orlando will coordinate a third center, pending IRB approval. Pirozzolo recently completed Sports medicine fellowships at the Ohio State University and Duke University.
Future centers will be coordinated by CO-PIs, Dr. Hal Goforth, widely acclaimed researcher on muscle glycogen metabolism from Point Loma Nazarene University and the Naval Research Center, and Dr. Fran Pirozzolo, Chairman of the Medical and Scientific Advisory Board of Go Healthy. Dr. Fran Pirozzolo was formerly the Chief of the Neuropsychology Service in the Department of Neurology at the Baylor College of Medicine. He was a Member of the National Academy of Sciences Committee on Techniques to Enhance Human Performance and has served on a number of NIH and NIMH advisory committees.
The study will be a double-blind crossover study of the efficacy of Cholesterade(R) in lowering cholesterol (total cholesterol and LDL) and triglycerides while increasing HDL and HDLC/LDLC ratio. The study will also employ a modified Experience Sampling Technique to measure the vitality of subjects throughout the day.
Charlie Caudle, CEO of Go Healthy, states that “We are very excited to be moving forward on studies that will expand on Dr. Cade’s work and which we believe will conclusively demonstrate that Cholesterade(R) will bring a dramatic, meaningful contribution to the improvement of health in the cholesterol and other areas, including obesity and diabetes. This delicious drink will now allow the medical community to provide a compliance vehicle to meet NIH guidelines for 10-25 grams of dietary soluble fiber during a 12 week period of Therapeutic Lifestyle Changes prior to consideration of statin intervention. Subsequent studies we are planning will delve into those other areas and demonstrate the vital importance of dietary soluble fiber in general wellness.”
Forward-Looking Statements Disclosure
This press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,”"believes,”"estimates,”"expects,”"intends,”"plans,”"seeks,”"will,” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risks, and uncertainties, and by reference to the underlying assumptions.
Contact:
Charlie Caudle
CEO - Go Healthy, Inc.
(888) 282-7256

Brokers and Analysts call
Aero Financial, Inc
972-265-7590

Go Healthy, Inc.